Organogenesis Holdings Inc. ORGO Debt-to-equity

Debt-to-equity at other companies

IAR

Integra LifeSciencesIART

1.9×+0.1×

MiMedx GroupMDXG

0.1×0.0×

SANUWAVE Health, Inc.SNWV

5.2×—

AxogenAXGN

0.1×-0.5×

Anika TherapeuticsANIK

0.2×0.0×

SolventumSOLV

1.2×-0.9×

FAQ

What is Organogenesis Holdings Inc.'s debt-to-equity?

Organogenesis Holdings Inc. (ORGO) reported debt-to-equity of 0.2× in Q2 2026.

How has Organogenesis Holdings Inc.'s debt-to-equity changed year-over-year?

Organogenesis Holdings Inc.'s debt-to-equity increased by 87.5% year-over-year, from 0.1× to 0.2×.

What is the long-term trend for Organogenesis Holdings Inc.'s debt-to-equity?

Over 5 years (2020 to 2025), Organogenesis Holdings Inc.'s debt-to-equity has grown at a -11.0% compound annual growth rate (CAGR), from 0.5× to 0.3×.

What does debt-to-equity mean?

Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.